{{expert|time=2018-02-01T21:37:27+00:00}}
{{medical}}
{{Infobox drug
| Verifiedfields = changed
| verifiedrevid = 459526640
| drug_name =
| IUPAC_name = (8''S'',9''R'',10''S'',11''S'',13''S'',14''S'',16''S'',17''R'')-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-[2-(propionyloxy)acetyl]-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3''H''-cyclopenta[''a'']phenanthren-17-yl propionate
| image = Beclometasone dipropionate.png
| width = 240
| image2 = Beclometasone-dipropionate-3D-balls.png
| width2 = 250
<!--Clinical data-->
| tradename =  Qvar, Beconase AQ, others
| Drugs.com = {{drugs.com|monograph|beclomethasone-dipropionate-eent}}
| MedlinePlus = a681047
| pregnancy_AU = B3
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = S2
| legal_CA = <!--                             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = POM
| legal_UK_comment = 但某些鼻噴劑為[[非处方药|非处方药]]
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| routes_of_administration = inhalation, nasal, topical
<!--Pharmacokinetic data-->
| bioavailability = Converted to beclometasone-17-monopropionate (17-BMP) during absorption
| protein_bound = 87% of 17-BMP to albumin and transcortin
| metabolism = By [[酯酶|esterase]] enzymes found in most tissues
| elimination_half-life = 2.8 小時
| excretion = 膽汁（60%）、腎臟（12%）
<!--Identifiers-->
| IUPHAR_ligand = 5894
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 5534-09-8
| ATC_prefix = A07
| ATC_suffix = EA07
| ATC_supplemental =  {{ATC|D07|AC15}}, {{ATC|R01|AD01}}, {{ATC|R03|BA01}}
| PubChem = 21700
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00394
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 20396
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 5B307S63B2
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 3002
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200500
<!--Chemical data-->
| C=28  
| H=37
| Cl=1  
| O=7
| molecular_weight = 521.042 g/mol
| smiles = O=C(OCC(=O)[C@]3(OC(=O)CC)[C@]2(C[C@H](O)[C@]4(Cl)[C@@]/1(\C(=C/C(=O)\C=C\1)CC[C@H]4[C@@H]2C[C@@H]3C)C)C)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = KUVIULQEHSCUHY-XYWKZLDCSA-N
}}
<!-- Definition and medical uses -->
'''貝克每松'''（Beclometasone dipropionate），是一種[[皮質類固醇|類固醇類藥物]]，為一種糖皮質素<ref name="AHFS2015" />，常見商品名為'''Qvar。'''<ref name="AHFS2015">{{cite web|url=http://www.drugs.com/monograph/beclomethasone-dipropionate.html|title=Beclomethasone Dipropionate|accessdate=2015-12-02|publisher=The American Society of Health-System Pharmacists}}</ref> 此藥物作為吸入器的藥粉、乳霜、藥片以及鼻噴劑<ref name="MHRA2015">{{cite web|url=http://www.mhra.gov.uk/spc-pil/?subsName=BECLOMETASONE%20DIPROPIONATE&pageID=SecondLevel|title=List of products: BECLOMETASONE DIPROPIONATE|accessdate=2015-12-06|website=MHRA}}</ref>。 吸入器藥粉常用於治療長期的[[哮喘|氣喘]]<ref name="AHFS2015" />。 乳霜型態的藥物則用於治療[[皮膚炎|皮膚炎]]和[[銀屑病|乾癬]]症<ref>{{cite web|url=http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1444971110586.pdf|title=Beclometasone dipropionate 0.25 mg/g Cream|accessdate=2015-12-06|website=MHRA}}</ref>。 藥片型態的藥物則用於治療[[溃疡性结肠炎|潰瘍性大腸炎]]<ref name="MHRA2015Pill">{{cite web|url=http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1353302219931.pdf|title=Clipper|accessdate=2015-12-06|website=MHRA|deadurl=yes|archiveurl=https://web.archive.org/web/20151208154434/http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1353302219931.pdf|archivedate=2015-12-08}}</ref>。 鼻噴劑形式的藥物則用於治療[[過敏性鼻炎|過敏性鼻炎]]與[[鼻息肉|鼻瘜肉]]<ref name="AHFS2015ENT">{{cite web|url=http://www.drugs.com/monograph/beclomethasone-dipropionate-eent.html|title=Beclomethasone Dipropionate eent|accessdate=2015-12-02|publisher=The American Society of Health-System Pharmacists}}</ref>。 

<!-- Side effects and mechanism -->
使用吸入器藥粉形式的藥物，常見的副作用為[[呼吸道感染|呼吸道的感染]]、頭痛以及喉頭發炎<!-- <ref name=AHFS2015/> -->。嚴重的副作用包括增加感染風險、[[白内障|白內障]]、[[庫興氏症候群|庫興氏症]]以及[[全身型過敏性反應|嚴重過敏的風險]]<ref name="AHFS2015" />。 長期使用藥片可能導致{{tsl|en|adrenal insufficiency|腎上腺機能不足}}、或是情緒和人格的轉變<ref name="MHRA2015Pill" />。 一般而言，孕婦使用吸入器型態的藥物是安全的<ref name="Ric2015a">{{cite book|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|first1=Richart|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=349|last1=Hamilton}}</ref>。

<!-- Society and culture -->
貝克每松於1962年被註冊為專利，並於1972年正式作為藥物使用<ref>{{cite book|url=https://books.google.ca/books?id=_J2ti4EkYpkC&pg=PA539|title=Pharmaceutical Manufacturing Encyclopedia.|first1=Edwin M.|date=2007|publisher=Elsevier|isbn=9780815518563|edition=3rd ed.|location=Burlington|page=539|last1=McPherson}}</ref>。 1976年此化學成分在美國被核准為藥物使用<ref name="AHFS2015" />。此藥物也被列入在[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]中，建議列為各公衛系統必備的基本藥物<ref>{{cite web|url=http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|title=WHO Model List of Essential Medicines|accessdate=2014-04-22|date=October 2013|format=PDF|publisher=[[世界卫生组织|World Health Organization]]|website=Apps.WHO.int}}</ref>。2014年，含有200劑量的呼吸劑型藥物，在[[開發中國家|開發中國家]]批發價約3.2美金<ref>{{cite web|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=BEC100I&s_year=2014&year=2014&str=100%20mcg%2Fdose&desc=Beclometasone&pack=new&frm=INHALER&rte=INH&class_code2=&supplement=&class_name=%28%29%3Cbr%3E|title=Beclometasone|accessdate=2015-12-06|website=International Drug Price Indicator Guide}}{{Dead link|date=2018年6月 |bot=InternetArchiveBot |fix-attempted=no }}</ref>。 在美國，一個月吸入劑型劑量大約花費50至100美金<ref name="Ric2015b">{{cite book|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|first1=Richart|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=451|last1=Hamilton}}</ref>。

== 參考文獻 ==
<references />
{{GlaxoSmithKline}}
[[Category:糖皮质激素|Category:糖皮质激素]]
[[Category:丙酸酯|Category:丙酸酯]]
[[Category:有机氯化合物|Category:有机氯化合物]]
[[Category:抗喘药|Category:抗喘药]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]